In Vitro Potentiation of BCNU Activity in Rat Brain Tumour Cells Pretreated with Misonidazole

Overview

Journal Br J Cancer

Specialty Oncology

Date 1984 Jun 1

PMID 6733025

Citations 1

Authors

D W Siemann

K Wolf

S Morrissey

K T Wheeler

Affiliations

Soon will be listed here.

Citing Articles

Chemopotentiation in vivo: no loss of sensitization with fractionation.

Hill S, Siemann D Br J Cancer. 1984; 50(4):509-17.

PMID: 6487517 PMC: 1976902. DOI: 10.1038/bjc.1984.208.

References

Rosenblum M, Wheeler K, Wilson C, Barker M, Knebel K . In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 1975; 35(6):1387-91. View

Levin V, Wilson C . Nitrosourea chemotherapy for primary malignant gliomas. Cancer Treat Rep. 1976; 60(6):719-24. View

Stratford I, Adams G, Horsman M, Kandaiya S, Rajaratnam S, Smith E . The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report. Cancer Clin Trials. 1980; 3(3):231-6. View

Twentyman P . The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU. Cancer Clin Trials. 1980; 3(3):253-6. View

Hall E . Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole. Br J Cancer. 1981; 44(2):201-7. PMC: 2010744. DOI: 10.1038/bjc.1981.171. View

Twentyman P . Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions. Br J Cancer. 1982; 45(4):565-70. PMC: 2010993. DOI: 10.1038/bjc.1982.93. View

McNally N . Enhancement of chemotherapy agents. Int J Radiat Oncol Biol Phys. 1982; 8(3-4):593-8. DOI: 10.1016/0360-3016(82)90691-5. View

Mulcahy R . Chemical properties of nitrosoureas: implications for interaction with misonidazole. Int J Radiat Oncol Biol Phys. 1982; 8(3-4):599-602. DOI: 10.1016/0360-3016(82)90692-7. View

Siemann D, Mulcahy R . Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole. Int J Radiat Oncol Biol Phys. 1982; 8(3-4):619-22. DOI: 10.1016/0360-3016(82)90697-6. View

10.

Brown J . The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. Int J Radiat Oncol Biol Phys. 1982; 8(3-4):675-82. DOI: 10.1016/0360-3016(82)90711-8. View

11.

Taylor Y, Bump E, Brown J . Studies on the mechanism of chemosensitization by misonidazole in vitro. Int J Radiat Oncol Biol Phys. 1982; 8(3-4):705-8. DOI: 10.1016/0360-3016(82)90717-9. View

12.

Siemann D . Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review. Int J Radiat Oncol Biol Phys. 1982; 8(6):1029-34. DOI: 10.1016/0360-3016(82)90172-9. View

13.

Millar B . Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer. Biochem Pharmacol. 1982; 31(15):2439-45. DOI: 10.1016/0006-2952(82)90051-x. View

14.

Lee F, Workman P . Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. Br J Cancer. 1983; 47(5):659-69. PMC: 2011404. DOI: 10.1038/bjc.1983.104. View

15.

Mulcahy R, Dembs N . Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro. Cancer Res. 1983; 43(8):3539-43. View

16.

Wheeler K, Wallen C, WOLF K, Siemann D . Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole. Br J Cancer. 1984; 49(6):787-93. PMC: 1976835. DOI: 10.1038/bjc.1984.122. View